Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 3
1993 2
1994 8
1995 2
1996 3
1997 5
1998 6
1999 3
2000 5
2002 1
2003 1
2004 2
2005 1
2007 2
2008 6
2009 6
2010 7
2011 7
2012 11
2013 3
2014 2
2015 2
2016 12
2017 2
2018 1
2019 18
2020 7
2021 10
2022 10
2023 21
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

157 results

Results by year

Filters applied: . Clear all
Page 1
Immunogenicity Parameters of Cancer Patients Receiving the mRNA Vaccine BNT162b2 While Obtaining Radiotherapy: A Longitudinal Cohort Evaluation.
Thöne P, Egger M, Geroldinger-Simic M, Kindermann H, Kocik L, Karasek N, Fischerlehner B, Spiegl K, Gruber G, Aschacher B, Dieplinger B, Clodi M, Geinitz H. Thöne P, et al. Among authors: clodi m. Vaccines (Basel). 2024 Mar 6;12(3):275. doi: 10.3390/vaccines12030275. Vaccines (Basel). 2024. PMID: 38543909 Free PMC article.
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis.
Agarwal R, Tu W, Farjat AE, Farag YMK, Toto R, Kaul S, Lawatscheck R, Rohwedder K, Ruilope LM, Rossing P, Pitt B, Filippatos G, Anker SD, Bakris GL; FIDELIO-DKD and FIGARO-DKD Investigators. Agarwal R, et al. Ann Intern Med. 2023 Dec;176(12):1606-1616. doi: 10.7326/M23-1023. Epub 2023 Dec 5. Ann Intern Med. 2023. PMID: 38048573 Clinical Trial.
[Overweight and obesity in adults: general principles of treatment and conservative management].
Brix JM, Andersen B, Aydinkoc-Tuzcu K, Beckerhinn P, Brossard-Eitzinger A, Cavini A, Ciardi C, Clodi M, Eichner M, Erlacher B, Fahrnberger M, Felsenreich DM, Francesconi C, Göbel B, Hölbing E, Hoppichler F, Huber J, Huber SL, Itariu BK, Jandrasitz B, Kiefer FW, Köhler G, Kruschitz R, Ludvik B, Malzner A, Moosbrugger A, Öfferlbauer-Ernst A, Parzer V, Prager G, Resl M, Ress C, Schelkshorn C, Scherer T, Sourji H, Stechemesser L, Stulnig T, Toplak H, Wakolbinger M, Vonbank A, Weghuber D. Brix JM, et al. Among authors: clodi m. Wien Klin Wochenschr. 2023 Nov;135(Suppl 6):706-720. doi: 10.1007/s00508-023-02270-9. Epub 2023 Oct 11. Wien Klin Wochenschr. 2023. PMID: 37821694 Free PMC article. German.
Erratum. Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study. Diabetes Care 2022;45:888-897.
Rossing P, Burgess E, Agarwal R, Anker SD, Filippatos G, Pitt B, Ruilope LM, Gillard P, MacIsaac RJ, Wainstein J, Joseph A, Brinker M, Roessig L, Scott C, Bakris GL; FIDELIO-DKD Investigators. Rossing P, et al. Diabetes Care. 2023 Sep 1;46(9):1721. doi: 10.2337/dc23-er09. Diabetes Care. 2023. PMID: 37310695 Free PMC article. No abstract available.
Simulation of bempedoic acid and ezetimibe in the lipid-lowering treatment pathway in Austria using the contemporary SANTORINI cohort of high and very high risk patients.
Toplak H, Bilitou A, Alber H, Auer J, Clodi M, Ebenbichler C, Fließer-Görzer E, Gelsinger C, Hanusch U, Ludvik B, Maca T, Schober A, Sock R, Speidl WS, Stulnig TM, Weitgasser R, Zirlik A, Koch M, Wienerroither S, Wolowacz SE, Diamand F, Catapano AL. Toplak H, et al. Among authors: clodi m. Wien Klin Wochenschr. 2023 Jul;135(13-14):364-374. doi: 10.1007/s00508-023-02221-4. Epub 2023 Jun 8. Wien Klin Wochenschr. 2023. PMID: 37286910 Free PMC article.
[Geriatric aspects for the management of diabetes mellitus (Update 2023)].
Huber J, Smeikal M, Saely CH, Stingl H, Clodi M, Lechleitner M, Fasching P. Huber J, et al. Among authors: clodi m. Wien Klin Wochenschr. 2023 Jan;135(Suppl 1):307-318. doi: 10.1007/s00508-022-02124-w. Epub 2023 Apr 20. Wien Klin Wochenschr. 2023. PMID: 37101051 Free PMC article. German.
[Hyperglycemia in critically ill].
Clodi M, Resl M, Abrahamian H, Föger B, Weitgasser R. Clodi M, et al. Wien Klin Wochenschr. 2023 Jan;135(Suppl 1):272-274. doi: 10.1007/s00508-023-02173-9. Epub 2023 Apr 20. Wien Klin Wochenschr. 2023. PMID: 37101048 Free PMC article. German.
[Position statement: surgery and diabetes mellitus (Update 2023)].
Kietaibl AT, Huber J, Clodi M, Abrahamian H, Ludvik B, Fasching P. Kietaibl AT, et al. Among authors: clodi m. Wien Klin Wochenschr. 2023 Jan;135(Suppl 1):256-271. doi: 10.1007/s00508-022-02121-z. Epub 2023 Apr 20. Wien Klin Wochenschr. 2023. PMID: 37101047 Free PMC article. German.
[Diabetes mellitus, coronary artery disease and heart disease (Update 2023)].
Clodi M, Saely CH, Hoppichler F, Resl M, Steinwender C, Stingl H, Wascher TC, Winhofer Y, Sourij H. Clodi M, et al. Wien Klin Wochenschr. 2023 Jan;135(Suppl 1):201-206. doi: 10.1007/s00508-023-02183-7. Epub 2023 Apr 20. Wien Klin Wochenschr. 2023. PMID: 37101042 Free PMC article. German.
[Diabetic kidney disease (update 2023) : Position paper of the Austrian Diabetes Association and the Austrian Society for Nephrology].
Sourij H, Edlinger R, Prischl FC, Kaser S, Horn S, Antlanger M, Paulweber B, Aberer F, Brix J, Cejka D, Stingl H, Kautzky-Willer A, Schmaldienst S, Clodi M, Rosenkranz A, Mayer G, Oberbauer R, Säemann M. Sourij H, et al. Among authors: clodi m. Wien Klin Wochenschr. 2023 Jan;135(Suppl 1):182-194. doi: 10.1007/s00508-022-02147-3. Epub 2023 Apr 20. Wien Klin Wochenschr. 2023. PMID: 37101040 Free PMC article. German.
[Lipids-Diagnosis and therapy in diabetes mellitus (Update 2023)].
Wascher TC, Paulweber B, Toplak H, Saely CH, Drexel H, Föger B, Hoppichler F, Stulnig T, Stingl H, Clodi M; Ausschuss Leitlinien. Wascher TC, et al. Among authors: clodi m. Wien Klin Wochenschr. 2023 Jan;135(Suppl 1):157-160. doi: 10.1007/s00508-023-02166-8. Epub 2023 Apr 20. Wien Klin Wochenschr. 2023. PMID: 37101037 Free PMC article. German.
[Diagnosis and insulin therapy of type 1 diabetes mellitus (Update 2023)].
Lechleitner M, Kaser S, Hoppichler F, Roden M, Weitgasser R, Ludvik B, Fasching P, Winhofer Y, Kautzky-Willer A, Schernthaner G, Prager R, Wascher TC, Clodi M. Lechleitner M, et al. Among authors: clodi m. Wien Klin Wochenschr. 2023 Jan;135(Suppl 1):98-105. doi: 10.1007/s00508-023-02182-8. Epub 2023 Apr 20. Wien Klin Wochenschr. 2023. PMID: 37101030 Free PMC article. German.
[Obesity and type 2 diabetes (Update 2023)].
Clodi M, Toplak H, Resl M, Brix J, Leitner DR, Harreiter J, Hoppichler F, Wascher TC, Schindler K, Ludvik B. Clodi M, et al. Wien Klin Wochenschr. 2023 Jan;135(Suppl 1):91-97. doi: 10.1007/s00508-023-02184-6. Epub 2023 Apr 20. Wien Klin Wochenschr. 2023. PMID: 37101029 Free PMC article. German.
[Nutrition for diabetic patients (Update 2023)].
Klammer C, Schindler K, Bugl R, Plazek D, Vötter M, Kirchner T, Martino C, Klammer-Martin J, Brix J, Dämon S, Hoppichler F, Kautzky-Willer A, Kruschitz R, Toplak H, Clodi M, Ludvik B. Klammer C, et al. Among authors: clodi m. Wien Klin Wochenschr. 2023 Jan;135(Suppl 1):62-77. doi: 10.1007/s00508-023-02170-y. Epub 2023 Apr 20. Wien Klin Wochenschr. 2023. PMID: 37101026 Free PMC article. German.
[Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2023)].
Clodi M, Abrahamian H, Brath H, Schernthaner G, Brix J, Ludvik B, Drexel H, Saely CH, Fasching P, Rega-Kaun G, Föger B, Francesconi C, Fröhlich-Reiterer E, Kautzky-Willer A, Harreiter J, Luger A, Resl M, Riedl M, Winhofer Y, Hofer SE, Hoppichler F, Huber J, Kaser S, Ress C, Lechleitner M, Aberer F, Mader JK, Sourij H, Toplak H, Paulweber B, Stechemesser L, Pieber T, Prager R, Stingl H, Stulnig T, Rami-Merhar B, Drexel H, Roden M, Schelkshorn C, Wascher TC, Weitgasser R, Zlamal-Fortunat S. Clodi M, et al. Wien Klin Wochenschr. 2023 Jan;135(Suppl 1):32-44. doi: 10.1007/s00508-023-02186-4. Epub 2023 Apr 20. Wien Klin Wochenschr. 2023. PMID: 37101023 Free PMC article. German.
[Other specific types of diabetes and exocrine pancreatic insufficiency (update 2023)].
Kaser S, Hofer SE, Kazemi-Shirazi L, Festa A, Winhofer Y, Sourij H, Brath H, Riedl M, Resl M, Clodi M, Stulnig T, Ress C, Luger A. Kaser S, et al. Among authors: clodi m. Wien Klin Wochenschr. 2023 Jan;135(Suppl 1):18-31. doi: 10.1007/s00508-022-02123-x. Epub 2023 Apr 20. Wien Klin Wochenschr. 2023. PMID: 37101022 Free PMC article. German.
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients.
Nissen SE, Lincoff AM, Brennan D, Ray KK, Mason D, Kastelein JJP, Thompson PD, Libby P, Cho L, Plutzky J, Bays HE, Moriarty PM, Menon V, Grobbee DE, Louie MJ, Chen CF, Li N, Bloedon L, Robinson P, Horner M, Sasiela WJ, McCluskey J, Davey D, Fajardo-Campos P, Petrovic P, Fedacko J, Zmuda W, Lukyanov Y, Nicholls SJ; CLEAR Outcomes Investigators. Nissen SE, et al. N Engl J Med. 2023 Apr 13;388(15):1353-1364. doi: 10.1056/NEJMoa2215024. Epub 2023 Mar 4. N Engl J Med. 2023. PMID: 36876740 Clinical Trial.
High Anti-CoV2S Antibody Levels at Hospitalization Are Associated with Improved Survival in Patients with COVID-19 Vaccine Breakthrough Infection.
Heinzl MW, Kolenchery L, Resl M, Klammer C, Black A, Obendorf F, Schinagl L, Feldbauer R, Pohlhammer J, Wagner T, Berger T, Dieplinger B, Clodi M. Heinzl MW, et al. Among authors: clodi m. Int J Environ Res Public Health. 2022 Nov 24;19(23):15581. doi: 10.3390/ijerph192315581. Int J Environ Res Public Health. 2022. PMID: 36497655 Free PMC article.
Glucose and lipopolysaccharide differentially regulate fibroblast growth factor 21 in healthy male human volunteers - A prospective cross-over trial.
Pohlhammer J, Heinzl MW, Klammer C, Feldbauer R, Rosenberger K, Resl M, Wagner T, Obendorf F, Egger-Salmhofer M, Dieplinger B, Clodi M. Pohlhammer J, et al. Among authors: clodi m. J Cell Mol Med. 2022 Dec;26(24):5998-6005. doi: 10.1111/jcmm.17614. Epub 2022 Nov 22. J Cell Mol Med. 2022. PMID: 36415151 Free PMC article. Clinical Trial.
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis.
Rossing P, Anker SD, Filippatos G, Pitt B, Ruilope LM, Birkenfeld AL, McGill JB, Rosas SE, Joseph A, Gebel M, Roberts L, Scheerer MF, Bakris GL, Agarwal R; FIDELIO-DKD and FIGARO-DKD Investigators. Rossing P, et al. Diabetes Care. 2022 Dec 1;45(12):2991-2998. doi: 10.2337/dc22-0294. Diabetes Care. 2022. PMID: 35972218 Free PMC article. Clinical Trial.
Biomarkers Predictive for In-Hospital Mortality in Patients with Diabetes Mellitus and Prediabetes Hospitalized for COVID-19 in Austria: An Analysis of COVID-19 in Diabetes Registry.
Aziz F, Stöcher H, Bräuer A, Ciardi C, Clodi M, Fasching P, Karolyi M, Kautzky-Willer A, Klammer C, Malle O, Aberer F, Pawelka E, Peric S, Ress C, Sourij C, Stechemesser L, Stingl H, Stulnig T, Tripolt N, Wagner M, Wolf P, Zitterl A, Moser O, Schelkshorn C, Kaser S, Sourij H, For The Covid-In Diabetes In Austria. Aziz F, et al. Among authors: clodi m. Viruses. 2022 Jun 13;14(6):1285. doi: 10.3390/v14061285. Viruses. 2022. PMID: 35746755 Free PMC article.
SUBCLINICAL KIDNEY INJURY IS CAUSED BY A MODERATE SINGLE INFLAMMATORY EVENT.
Heinzl MW, Resl M, Klammer C, Fellinger P, Schinagl L, Obendorf F, Feldbauer R, Pohlhammer J, Wagner T, Egger M, Dieplinger B, Clodi M. Heinzl MW, et al. Among authors: clodi m. Shock. 2022 Jul 1;58(1):14-19. doi: 10.1097/SHK.0000000000001942. Epub 2022 Jul 19. Shock. 2022. PMID: 35616594 Free PMC article.
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study.
Rossing P, Burgess E, Agarwal R, Anker SD, Filippatos G, Pitt B, Ruilope LM, Gillard P, MacIsaac RJ, Wainstein J, Joseph A, Brinker M, Roessig L, Scott C, Bakris GL; FIDELIO-DKD Investigators. Rossing P, et al. Diabetes Care. 2022 Apr 1;45(4):888-897. doi: 10.2337/dc21-1944. Diabetes Care. 2022. PMID: 35061867 Free PMC article. Clinical Trial.
COVID-19 In-Hospital Mortality in People with Diabetes Is Driven by Comorbidities and Age-Propensity Score-Matched Analysis of Austrian National Public Health Institute Data.
Aziz F, Aberer F, Bräuer A, Ciardi C, Clodi M, Fasching P, Karolyi M, Kautzky-Willer A, Klammer C, Malle O, Pawelka E, Pieber T, Peric S, Ress C, Schranz M, Sourij C, Stechemesser L, Stingl H, Stöcher H, Stulnig T, Tripolt N, Wagner M, Wolf P, Zitterl A, Reisinger AC, Siller-Matula J, Hummer M, Moser O, von-Lewinski D, Eller P, Kaser S, Sourij H. Aziz F, et al. Among authors: clodi m. Viruses. 2021 Nov 30;13(12):2401. doi: 10.3390/v13122401. Viruses. 2021. PMID: 34960670 Free PMC article.
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial.
Peyrin-Biroulet L, Hart A, Bossuyt P, Long M, Allez M, Juillerat P, Armuzzi A, Loftus EV Jr, Ostad-Saffari E, Scalori A, Oh YS, Tole S, Chai A, Pulley J, Lacey S, Sandborn WJ; HICKORY Study Group. Peyrin-Biroulet L, et al. Lancet Gastroenterol Hepatol. 2022 Feb;7(2):128-140. doi: 10.1016/S2468-1253(21)00298-3. Epub 2021 Nov 17. Lancet Gastroenterol Hepatol. 2022. PMID: 34798039 Free article. Clinical Trial.
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study.
Danese S, Colombel JF, Lukas M, Gisbert JP, D'Haens G, Hayee B, Panaccione R, Kim HS, Reinisch W, Tyrrell H, Oh YS, Tole S, Chai A, Chamberlain-James K, Tang MT, Schreiber S; GARDENIA Study Group. Danese S, et al. Lancet Gastroenterol Hepatol. 2022 Feb;7(2):118-127. doi: 10.1016/S2468-1253(21)00294-6. Epub 2021 Nov 17. Lancet Gastroenterol Hepatol. 2022. PMID: 34798038 Free article. Clinical Trial.
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.
Pitt B, Filippatos G, Agarwal R, Anker SD, Bakris GL, Rossing P, Joseph A, Kolkhof P, Nowack C, Schloemer P, Ruilope LM; FIGARO-DKD Investigators. Pitt B, et al. N Engl J Med. 2021 Dec 9;385(24):2252-2263. doi: 10.1056/NEJMoa2110956. Epub 2021 Aug 28. N Engl J Med. 2021. PMID: 34449181 Clinical Trial.
Subgroup analyses in randomized clinical trials: value and limitations. Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy.
Drexel H, Pocock SJ, Lewis BS, Saely CH, Kaski JC, Rosano GMC, Tautermann G, Huber K, Dopheide JF, Mader A, Niessner A, Savarese G, Schmidt TA, Semb AG, Tamargo J, Wassmann S, Clodi M, Kjeldsen KP, Agewall S. Drexel H, et al. Among authors: clodi m. Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):302-310. doi: 10.1093/ehjcvp/pvab048. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 34180504 Review. No abstract available.
Storm of Cardiovascular Markers After LPS Administration in Human Volunteers.
Resl M, Heinzl MW, Klammer C, Egger M, Feldbauer R, Pohlhammer J, Dieplinger B, Clodi M. Resl M, et al. Among authors: clodi m. J Cardiovasc Transl Res. 2021 Oct;14(5):941-947. doi: 10.1007/s12265-021-10109-9. Epub 2021 Mar 22. J Cardiovasc Transl Res. 2021. PMID: 33751402 Free PMC article.
Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitus.
Prausmüller S, Resl M, Arfsten H, Spinka G, Wurm R, Neuhold S, Bartko PE, Goliasch G, Strunk G, Pavo N, Clodi M, Hülsmann M. Prausmüller S, et al. Among authors: clodi m. Cardiovasc Diabetol. 2021 Feb 2;20(1):34. doi: 10.1186/s12933-021-01221-w. Cardiovasc Diabetol. 2021. PMID: 33530999 Free PMC article.
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.
Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, Kolkhof P, Nowack C, Schloemer P, Joseph A, Filippatos G; FIDELIO-DKD Investigators. Bakris GL, et al. N Engl J Med. 2020 Dec 3;383(23):2219-2229. doi: 10.1056/NEJMoa2025845. Epub 2020 Oct 23. N Engl J Med. 2020. PMID: 33264825 Free article. Clinical Trial.
COVID-19 fatality prediction in people with diabetes and prediabetes using a simple score upon hospital admission.
Sourij H, Aziz F, Bräuer A, Ciardi C, Clodi M, Fasching P, Karolyi M, Kautzky-Willer A, Klammer C, Malle O, Oulhaj A, Pawelka E, Peric S, Ress C, Sourij C, Stechemesser L, Stingl H, Stulnig T, Tripolt N, Wagner M, Wolf P, Zitterl A, Kaser S; COVID-19 in diabetes in Austria study group. Sourij H, et al. Among authors: clodi m. Diabetes Obes Metab. 2021 Feb;23(2):589-598. doi: 10.1111/dom.14256. Epub 2020 Dec 4. Diabetes Obes Metab. 2021. PMID: 33200501 Free PMC article.
Effect of high-dose vitamin D3 on 28-day mortality in adult critically ill patients with severe vitamin D deficiency: a study protocol of a multicentre, placebo-controlled double-blind phase III RCT (the VITDALIZE study).
Amrein K, Parekh D, Westphal S, Preiser JC, Berghold A, Riedl R, Eller P, Schellongowski P, Thickett D, Meybohm P; VITDALIZE Collaboration Group. Amrein K, et al. BMJ Open. 2019 Nov 12;9(11):e031083. doi: 10.1136/bmjopen-2019-031083. BMJ Open. 2019. PMID: 31722941 Free PMC article.
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Nowack C, Kolkhof P, Ferreira AC, Schloemer P, Filippatos G; on behalf of the FIDELIO-DKD study investigators; FIDELIO-DKD study investigators. Bakris GL, et al. Am J Nephrol. 2019;50(5):333-344. doi: 10.1159/000503713. Epub 2019 Oct 25. Am J Nephrol. 2019. PMID: 31655812 Free PMC article. Clinical Trial.
157 results